Adamis Pharmaceuticals reported 17.77M in Cash and Equivalent for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Adamis Pharmaceuticals ADMP:US 17.77M 5.45M
Adma Biologics ADMA:US $ 69.5M 18.42M
Brainstorm Cell Therapeutics BCLI:US $ 15.15M 3.7M
Cara Therapeutics CARA:US $ 21.36M 7.91M
Cerulean Pharma CERU:US $ 39.32M 12.36M
GlaxoSmithKline GSK:LN 10967M 6693M
Glaxosmithkline GSK:US $ 10967M 6693M
Merk MRK:US $ 8556M 460M
Pfizer PFE:US $ 2470M 526M
Redhill Biopharma RDHL:US $ 28.85M 0.63M